In the Matter of Pure H20 Bio-Technologies, Inc.; Order of Suspension of Trading
---
identifier: "/us/fr/2013-28447"
source: "fr"
legal_status: "authoritative_unofficial"
title: "In the Matter of Pure H20 Bio-Technologies, Inc.; Order of Suspension of Trading"
title_number: 0
title_name: "Federal Register"
section_number: "2013-28447"
section_name: "In the Matter of Pure H20 Bio-Technologies, Inc.; Order of Suspension of Trading"
positive_law: false
currency: "2013-11-26"
last_updated: "2013-11-26"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Securities and Exchange Commission"
document_number: "2013-28447"
document_type: "notice"
publication_date: "2013-11-26"
agencies:
- "Securities and Exchange Commission"
fr_citation: "78 FR 70617"
fr_volume: 78
docket_ids:
- "File No. 500-1"
---
# In the Matter of Pure H20 Bio-Technologies, Inc.; Order of Suspension of Trading
It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of Pure H20 Bio-Technologies, Inc. because questions have arisen as to its operating status, if any.
The Commission is of the opinion that the public interest and the protection of the investors require a suspension of trading in the securities of the above-listed company.
Therefore, it is ordered, pursuant to Section 12(k) of the Securities Exchange Act of 1934, that trading in the securities of the above-listed company is suspended for the period from 9:30 a.m. EST on November 22, 2013, through 11:59 p.m. EST on December 6, 2013.
By the Commission.
Jill M. Peterson,
Assistant Secretary,